Ginsenoside Rg1 protects mouse podocytes from aldosterone-induced injury in vitro
Tóm tắt
Từ khóa
Tài liệu tham khảo
Mundel P, Shankland SJ . Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005–15.
Barisoni L, Mundel P . Podocyte biology and the emerging understanding of podocyte diseases. Am J Nephrol 2003; 23: 353–60.
Hartleben B, Gödel M, Meyer-Schwesinger C, Liu S, Ulrich T, Köbler S, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010; 120: 1084–96.
Kerjaschki D . Caught flat-footed: podocyte damage and the molecular bases of focal glomerulosclerosis. J Clin Invest 2001; 108: 1583–7.
Chuang P, Yu Q, Fang W, Uribarri J, He J . Advanced glycation endproducts induce podocyte apoptosis by activation of the FOXO4 transcription factor. Kidney Int 2007; 72: 965–76.
Nagase M . Activation of the aldosterone/mineralocorticoid receptor system in chronic kidney disease and metabolic syndrome. Clin Exp Nephrol 2010; 14: 303–14.
Han K, Kang Y, Han S, Jee Y, Lee M, Han J, et al. Spironolactone ameliorates renal injury and connective tissue growth factor expression in type II diabetic rats. Kidney Int 2006; 70: 111–20.
Sato A, Hayashi K, Naruse M, Saruta T . Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension 2003; 41: 64–8.
Nagase M, Yoshida S, Shibata S, Nagase T, Gotoda T, Ando K, et al. Enhanced aldosterone signaling in the early nephropathy of rats with metabolic syndrome: possible contribution of fat-derived factors. J Am Soc Nephrol 2006; 17: 3438–46.
Patni H, Mathew JT, Luan L, Franki N, Chander PN, Singhal PC . Aldosterone promotes proximal tubular cell apoptosis: role of oxidative stress. Am J Physiol-Renal 2007; 293: F1065–F71.
Nishiyama A, Yao L, Nagai Y, Miyata K, Yoshizumi M, Kagami S, et al. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Hypertension 2004; 43: 841–8.
Shibata S, Nagase M, Yoshida S, Kawachi H, Fujita T . Podocyte as the target for aldosterone roles of oxidative stress and Sgk1. Hypertension 2007; 49: 355–64.
Zhu C, Huang S, Yuan Y, Ding G, Chen R, Liu B, et al. Mitochondrial dysfunction mediates aldosterone-induced podocyte damage: a therapeutic target of PPARγ. Am J Pathol 2011; 178: 2020–31.
Su M, Dhoopun AR, Yuan Y, Huang S, Zhu C, Ding G, et al. Mitochondrial dysfunction is an early event in aldosterone-induced podocyte injury. Am J Physiol-Renal 2013; 305: F520–31.
Yadav A, Vallabu S, Arora S, Tandon P, Slahan D, Teichberg S, et al. ANG II promotes autophagy in podocytes. Am J Physiol-Cell Physiol 2010; 299: C488–96.
Scherz-Shouval R, Elazar Z . ROS, mitochondria and the regulation of autophagy. Trends Cell Biol 2007; 17: 422–7.
Xie Z, Klionsky DJ . Autophagosome formation: core machinery and adaptations. Nat Cell Biol 2007; 9: 1102–9.
Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19: 5720–8.
Yue Z, Jin S, Yang C, Levine AJ, Heintz N . Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci U S A 2003; 100: 15077–82.
Butler D, Brown QB, Chin DJ, Batey L, Karim S, Mutneja MS, et al. Cellular responses to protein accumulation involve autophagy and lysosomal enzyme activation. Rejuv Res 2005; 8: 227–37.
Mochizuki M, Yoo YC, Matsuzawa K, Sato K, Saiki I, TONo-oKA S, et al. Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside-Rb2, 20 (R)-and 20 (S)-ginsenoside-Rg3, of red ginseng. Biol Pharm Bull 1995; 18: 1197–202.
Li L, Sheng YX, Zhang JL, Wang SS, Guo DA . High-performance liquid chromatographic assay for the active saponins from Panax notoginseng in rat tissues. Biomed Chromatogr 2006; 20: 327–35.
Zhang MH, Fan J, Xie X, Deng Y, Chen Y, Zhen R, et al. Ginsenoside-Rg1 protects podocytes from complement mediated injury. J Ethnopharmacol 2011; 137: 99–107.
Mundel P, Reiser J, Pavenstädt H, Davidson G, Kriz W, Zeller R . Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp Cell Res 1997; 236: 248–58.
Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, et al. Transforming growth factor-β regulates tubular epithelial-myofibroblast transdifferentiation in vitro. Kidney Int 1999; 56: 1455–67.
Colussi G, Catena C, Lapenna R, Nadalini E, Chiuch A, Sechi LA . Insulin resistance and hyperinsulinemia are related to plasma aldosterone levels in hypertensive patients. Diabetes Care 2007; 30: 2349–54.
Hene R, Boer P, Koomans H, Mees E . Plasma aldosterone concentrations in chronic renal disease. Kidney Int 1982; 21: 98–101.
Ibrahim HN, Rosenberg ME, Hostetter TH . Role of the renin-angiotensin-aldosterone system in the progression of renal disease: a critical review. Semin Nephrol 1997: 431–40.
Azad MB, Chen Y, Gibson SB . Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal 2009; 11: 777–90.
Mizushima N, Levine B, Cuervo AM, Klionsky DJ . Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069–75.
Periyasamy-Thandavan S, Jiang M, Wei Q, Smith R, Yin XM, Dong Z . Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int 2008; 74: 631–40.
Vicencio JM, Galluzzi L, Tajeddine N, Ortiz C, Criollo A, Tasdemir E, et al. Senescence, apoptosis or autophagy? Gerontology 2008; 54: 92–9.
Owen R . Ginseng: a pharmacological profile. Drugs Today 1981; 17: 343–51.
Xuan Y, Li YL, Zhao RS, Wu GD, Wang R, Li B, et al. Renal protective effect of ginsenoside against acute renal failure and nitronergic mechanism in PCT. J Dalian Med Univ 2009; 31: 279–82.
Xie X, Liu H, Zuo C, Deng Y, Fan J . The effect of ginsenoside Rg1 on the renal interstitial fibrosis of UUO rat. J Sichuan Univ Med Sci Edi 2008; 39: 218.